Negotiating Global Health Policies

Tensions and Dilemmas
Erscheinungsjahr 2025
ISBN: 978-3-031-99846-1
Verlag: Springer

Buch, Englisch, 88 Seiten, Format (B × H): 155 mm x 235 mm, Gewicht: 172 g

Reihe: SpringerBriefs in Public Health

This book presents reflections and research that highlight tensions in the ongoing negotiations on pandemic preparedness treaties and revisions to the International Health Regulations, underscoring the geopolitical divide between developed and developing countries. It advocates regional health initiatives as a response to the multilateral impasse and reflects on the erosion of foundational public health concepts such as "essential medicines". 

New pandemics are inevitable. How can we best prepare for them and, above all, how can we avoid the mistakes and injustices made during the COVID-19 pandemic? Negotiations are underway to formulate a binding international treaty on prevention and preparedness to ensure fairer responses to future pandemics. This book is intended as a critical contribution to the current debates.

How can equitable access to medicines and diagnostics be guaranteed when they are produced in a small number of countries? How can we explain the fact that current funding for cooperation in the field of health is in the hands of a small group of Northern countries and foundations from the North? How can the role of the World Health Organization be strengthened? WHO now plays only a minor role in coordinating public health policies. How is it that the concept of “essential medicines”, a major advance in public health policy, is being replaced by that of “medical countermeasures”, a term more in line with the private sectors?

Preparing for future pandemics forces us to ask ourselves: how can we safeguard the general interest, the defense of human rights and public health?

is essential reading for negotiators from the 194 member countries of the World Health Organization (WHO), the World Trade Organization (WTO), and the World Intellectual Property Organization (WIPO) who participate in international negotiations on health and development. Academics and students of medicine, health sciences, law, sociology and political science, as well as intergovernmental organizations and non-governmental organizations who work on access to medicines and global health issues, also would find the book of interest.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Velásquez, Germán

Fachgebiete

• Sozialwissenschaften Medien- und Kommunikationswissenschaften Medienwissenschaften
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Public Health, Gesundheitsmanagement, Gesundheitsökonomie, Gesundheitspolitik
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Gesundheitssystem, Gesundheitswesen
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin
• Sozialwissenschaften Politikwissenschaft Politikwissenschaft Allgemein Politische Theorie, Politische Philosophie

Inhaltsverzeichnis

1. Introduction.- 2. Current Challenges and Possible Future Scenarios for Global Health.- 3. The Origins and Purpose of Global Health Financing.- 4. WHO Negotiations on a Pandemic Treaty and the International Health Regulations Adopted in 2024.- 5. Building a Latin American and Caribbean Medicines Agency.- 6. From the Concept of "Essential Medicines" to That of "Medical Countermeasures".- 7. The Announcement of the United States' Withdrawal From the WHO: "Shooting Oneself in the Foot...".- 8. Final Remarks and Possible Way Forward.- . Appendix.

Über Autor(innen)

Germán Velásquez is Special Adviser, Policy and Health of the South Centre in Geneva, Switzerland. Previously, he was Director of the Secretariat on Public Health, Innovation and Intellectual Property at WHO. He represented WHO at the WTO TRIPS Council from 2001 to 2010. He is the author and co-author of numerous publications on health economics and medicines, health insurance schemes, globalization, international trade agreements, intellectual property and access to medicines.

He obtained a Master’s degree in Economics and a PhD in Health Economics from Sorbonne University, Paris. In 2010, he received a Honoris Causa PhD on Public Health from the University of Caldas, Colombia and in 2015 he received another Honoris Causa PhD from the Faculty of Medicine of the Complutense University of Madrid, Spain.